Related by context. All words. (Click for frequent words.) 73 bladder cancers 72 pancreatic adenocarcinoma 71 renal tumors 71 epithelial tumors 70 malignant pleural mesothelioma 70 invasive ductal 70 gastric adenocarcinoma 70 colorectal carcinoma 70 adenocarcinomas 69 skeletal metastases 69 pancreatic cancers 69 nasopharyngeal carcinoma 69 nonmelanoma skin cancers 69 hamartomas 69 serous ovarian cancer 69 gastrointestinal cancers 68 gastric carcinoma 68 lung carcinomas 68 prostate carcinoma 68 pancreatic lung 68 hepatocellular carcinoma 68 hepatocellular carcinoma HCC 68 mesotheliomas 68 peritoneal carcinomatosis 68 lobular carcinoma 67 uveal melanoma 67 endometrial cancers 67 prostate adenocarcinoma 67 renal cell carcinomas 67 GISTs 67 breast endometrial 67 neuroendocrine tumors 67 neoplasms 67 prostate cancers 67 seminoma 67 breast pancreatic 67 carcinoid tumors 67 precursor lesions 67 colorectal gastric 66 Gastric cancer 66 metachronous 66 neoplasm 66 basal cell carcinoma BCC 66 gastric cancer 66 malignant neoplasm 66 paragangliomas 66 adenocarcinoma 66 carcinomas 66 squamous cell carcinoma SCC 66 epithelial cancers 66 MALT lymphoma 66 prostate pancreatic 66 urothelial carcinoma 66 breast carcinomas 66 astrocytomas 66 colorectal tumors 66 adrenocortical cancer 66 colorectal cancer CRC 66 familial pancreatic cancer 66 situ CIS 66 soft tissue sarcomas 66 Squamous 66 neuroblastomas 66 cholangiocarcinoma 66 malignant lymphoma 66 cancers 65 colorectal cancers 65 premalignant lesions 65 adenomatous 65 prostate carcinomas 65 pulmonary metastases 65 ADPKD 65 nasopharyngeal cancer 65 ovarian lung 65 ovarian breast 65 carcinoid 65 lung cancers 65 malignant growths 65 cirrhosis liver failure 65 ovarian pancreatic 65 neoplastic 65 intestinal metaplasia 65 mucinous 65 malignancies 65 cryptococcosis 65 esophageal cancers 65 prostate cancer CaP 65 idiopathic myelofibrosis 65 myeloproliferative disorders 65 Basal cell 64 esophageal squamous cell carcinoma 64 nonmetastatic 64 osteosarcomas 64 pancreatic prostate 64 basal cell carcinomas 64 atrophic gastritis 64 nodal metastasis 64 HNSCC 64 hepatocellular carcinomas 64 Sezary syndrome 64 premalignant 64 testicular cancers 64 hyperplastic 64 renal carcinoma 64 papillary renal cell carcinoma 64 Helicobacter pylori infection 64 paraganglioma 64 liver metastasis 64 lymphocytic 64 malignant lesions 64 carcinoma HCC 64 tumors 64 ductal cancer 64 carcinoma 64 unresectable tumors 64 papillary 64 ductal breast cancer 64 pilocytic astrocytomas 64 HCV infections 64 NMIBC 64 situ LCIS 64 Papillary 64 lobular cancer 64 EGFR mutations 64 esophageal tumors 64 metastatic bladder 63 bowel cancers 63 advanced adenomas 63 hepatocellular cancer 63 neoplasias 63 colorectal adenocarcinoma 63 prostate cancer PCa 63 ovarian carcinoma 63 invasive ductal carcinoma 63 benign neoplasms 63 metastatic gastric 63 HBeAg negative 63 essential thrombocythemia 63 Cholangiocarcinoma 63 lung tumors 63 IDH1 mutation 63 metastatic colorectal 63 Leukemias 63 primary hyperparathyroidism 63 cervical neoplasia 63 node metastases 63 axillary lymph nodes 63 epithelioid 63 Alessandro Riva 63 meningiomas 63 proliferative diabetic retinopathy 63 urothelial cancer 63 pancreatic ovarian 63 pleural mesothelioma 63 endocrine tumors 63 neoplastic lesions 63 seminomas 63 myeloproliferative neoplasms 63 neoplasia 63 colon cancers 63 cervical breast 63 neurofibromas 63 fallopian tube carcinoma 63 distant metastasis 63 nonalcoholic steatohepatitis NASH 63 metastases 63 Radical prostatectomy 63 cell carcinomas 63 histologic subtype 63 mtDNA mutations 63 invasive lobular 63 ovarian cancers 63 nonsmall cell lung cancer 63 Sjögren syndrome 63 carcinoids 63 papillary carcinoma 63 oligodendrogliomas 63 Squamous cell 63 cervical carcinoma 63 endometrial hyperplasia 63 adenoma 63 lung adenocarcinomas 63 atherosclerotic lesions 63 metastatic melanomas 63 leiomyomas 63 T1a 63 basal cell cancers 63 HER2 positive cancers 63 monogenic 63 tumor xenograft models 63 leukaemias 63 ErbB2 positive 63 gastrointestinal stromal tumor 62 colorectal lung 62 metastatic lesions 62 CP CPPS 62 malignancy 62 nodular melanoma 62 metastatic pancreatic 62 grade cervical intraepithelial 62 squamous cell cancers 62 cell lymphoma ALCL 62 lymphoma subtypes 62 cutaneous melanoma 62 hepatic cirrhosis 62 Chronic pancreatitis 62 Epstein Barr virus EBV 62 liver metastases 62 colon tumors 62 EGFR mutation 62 systemic scleroderma 62 TTR gene 62 GIST tumors 62 lymph node metastases 62 metastatic lymph nodes 62 lung adenocarcinoma 62 neuroendocrine carcinoma 62 schwannomas 62 malignant neoplasms 62 K ras mutations 62 malignant fibrous histiocytoma 62 squamous cell lung cancer 62 ovarian colon 62 pleomorphic 62 Gliomas 62 histological subtype 62 CYT# potent vascular disrupting 62 advanced hepatocellular carcinoma 62 lobular carcinomas 62 intestinal polyps 62 geographic atrophy 62 malignant lymphomas 62 metastatic tumors 62 malignant prostate 62 sarcomatoid 62 lymph node metastasis 62 pituitary adenomas 62 supratentorial 62 Endometrial cancer 62 EGFR inhibitors 62 laryngeal cancer 62 Candida infection 62 metastatic lung cancer 62 neuroendocrine cancers 62 colorectal liver 62 pancreatic carcinoma 62 metastatic bone 62 invasive carcinoma 62 recurrent glioblastoma 62 gastric cardia 62 biliary cancer 62 tumoral 62 Chronic lymphocytic leukemia 62 hormone receptor negative 62 N. gonorrhoeae 62 pulmonary metastasis 62 lymphomas 62 carcinomatosis 62 lung metastasis 62 H pylori 62 squamous cell 62 Stomach cancer 62 angiosarcoma 62 leukemias lymphomas 62 H. pylori infection 62 chronic HBV infection 62 NAFLD 62 Leydig cell 62 myelofibrosis polycythemia vera 62 Polycythemia vera 62 oesophageal 62 chronic periodontitis 62 lipid abnormalities 62 BRCA1 mutation carriers 61 LHRH receptor positive 61 grade gliomas 61 B Cell Lymphoma 61 colorectal adenoma 61 endocrine therapies 61 liposarcoma 61 pheochromocytoma 61 CDH1 61 Barrett esophagus BE 61 metastatic cancers 61 metastatic neuroendocrine tumors 61 Colon polyps 61 breast carcinoma 61 Carcinoid tumors 61 metastatic prostate 61 pancreatic NET 61 myeloproliferative diseases 61 carcinoid tumor 61 hereditary predisposition 61 lichen planus 61 MGUS 61 malignant pancreatic 61 ependymomas 61 anaplastic 61 BRAF mutation 61 sCJD 61 squamous cell carcinomas 61 tumors GIST 61 oral squamous cell 61 essential thrombocythemia ET 61 cervical lymph nodes 61 cystic lesions 61 contralateral breast 61 kidney urologic 61 familial amyloidotic polyneuropathy FAP 61 molecular abnormalities 61 cisplatin resistant 61 basal cell skin 61 osteoporotic vertebral fractures 61 chronic prostatitis 61 leiomyosarcoma 61 colorectal polyps 61 liver scarring 61 pT2 61 node metastasis 61 atypical hyperplasia 61 metastatic disease 61 astrocytoma 61 curable cancers 61 oesophageal adenocarcinoma 61 Aspergillus species 61 prognostic markers 61 squamous carcinoma 61 ovarian tumors 61 p# mutations 61 Metastases 61 anemias 61 rectal cancers 61 renal cell carcinoma 61 PAOD 61 Squamous cell carcinomas 61 cytoreductive surgery 61 Hepatocellular Carcinoma HCC 61 nonalcoholic steatohepatitis 61 papillomas 61 underwent resection 61 ductal carcinomas 61 ependymoma 61 miRs 61 eccrine 61 adenoid cystic carcinoma 61 nasopharyngeal carcinoma NPC 61 castration resistant 61 Surgical resection 61 invasive ductal carcinomas 61 ALK mutations 61 prostate colon 61 esophageal adenocarcinoma 61 grade serous ovarian 61 neovascular diseases 61 candidemia 61 endometrial carcinoma 61 hormone gastrin 61 melanocytic nevi 61 squamous cell cancer 61 distant metastases 61 metastatic renal 61 IDH mutations 61 thyroid carcinomas 61 Anaplastic 61 colorectal polyp 61 distal colon cancer 61 completely resected 61 prostate breast 61 androgen independent 61 brain metastases 61 Basal cell carcinoma 61 lung pancreatic 61 adenomatous polyps 61 Prostatitis 60 leukemia lymphomas 60 resectable 60 recurrent glioblastoma multiforme 60 HER2 positive 60 superficial bladder cancer 60 Hurthle cell 60 PNET 60 eIF 4E 60 sarcomas 60 oesophageal cancers 60 squamous cell carcinoma 60 breast cancers 60 pancreatic neuroendocrine 60 benign moles 60 thyroid nodules 60 HER2 overexpression 60 untreated celiac disease 60 SSc 60 nonmelanoma 60 pancreatic gastric 60 colorectum 60 mycosis fungoides 60 lobular 60 peritoneal cancer 60 Metastatic breast cancer 60 leukemia AML 60 WT1 60 epithelial ovarian 60 cytoreduction 60 Basal Cell 60 acute myeloid 60 bronchogenic carcinoma 60 fluoroquinolone resistant 60 gastrointestinal stromal tumors GISTs 60 Cryptococcus neoformans 60 metaplasia 60 PCNSL 60 cervical uterine 60 bladder augmentation 60 choriocarcinoma 60 cranial irradiation 60 NPM1 60 leukemia ALL 60 chronic pancreatitis 60 lobular breast cancer 60 histologic subtypes 60 differentiated thyroid 60 gastrointestinal stromal tumors 60 FGFR2 60 myelomas 60 extracranial 60 EGFR tyrosine kinase inhibitors 60 BMPR2 60 lupus erythematosus 60 neuroblastoma tumors 60 operable breast cancer 60 esophagogastric 60 steatohepatitis 60 lung metastases 60 mammary tumors 60 TNF blocker therapy 60 Glioblastomas 60 locoregional recurrence 60 advanced adenoma 60 extramedullary 60 basal cell nevus syndrome 60 TTR amyloidosis 60 staphylococcal infections 60 Diabetic nephropathy 60 NSCLC 60 hepatocellular 60 ductal adenocarcinoma 60 GBM tumors 60 PCa 60 BRAF V#E 60 neurological manifestations 60 basal cell cancer 60 thymoma 60 antiproliferative effects 60 MLL AF9 60 invasive candidiasis 60 squamous 60 hypermethylation 60 histological subtypes 60 FLT3 60 histologies 60 cortical dysplasia 60 ccRCC 60 Atypical Hemolytic Uremic Syndrome 60 colorectal neoplasms 60 GSTT1 60 carotid stenosis 60 BCG refractory carcinoma 60 diabetic microvascular complications 60 gastric atrophy 60 Malignant mesothelioma 60 incidentalomas 60 intravesical therapy 60 Chronic Prostatitis 60 T1c 60 INCB# [003] 60 parathyroid carcinoma 60 leiomyoma 60 prostate lung 60 alveolar rhabdomyosarcoma 60 hematological diseases 60 pheochromocytomas 60 metastatic RCC 60 metastatic cancer 60 lymph node involvement 60 malignant brain 60 molecular subtypes 60 biliary tract cancer 60 metastatic malignant melanoma 60 glioblastomas 60 immunocompetent 60 BRAF mutations 60 castrate resistant 60 dysplastic nevi 60 lymphoproliferative disorders 60 HER2 amplification 60 benign nodules 60 hypopharynx 59 common hematologic malignancy 59 KRAS mutation 59 PHPT 59 anti angiogenic therapy 59 colorectal cancer 59 esophageal gastric 59 varices 59 recurrent NSCLC 59 lung colorectal 59 ABCB1 59 thyroid cancers 59 T2DM 59 Gleevec resistant 59 hepatoma 59 Hepatocellular carcinoma HCC 59 chronic granulomatous disease 59 bladder tumors 59 EGFR mutant 59 neurofibroma 59 breast tumors 59 basal cell 59 ANCA associated 59 papillary thyroid cancer 59 trans retinoic acid 59 oropharyngeal cancer 59 mutated KRAS gene 59 Nodules 59 Glioblastoma Multiforme GBM 59 microvascular complications 59 rs# [002] 59 adenomatous polyp 59 NAT2 59 Nasal polyps 59 localized renal 59 Epstein Barr Virus EBV 59 precancerous cervical 59 cyclin E 59 secondary hyperparathyroidism 59 bladder prostate 59 HbF 59 subependymal giant cell 59 Carcinoma 59 EBV infection 59 carcinoma HNSCC 59 aplasia 59 desmoplastic 59 preoperative chemotherapy 59 Legg Calvé Perthes disease 59 idiopathic PAH 59 CTAP# Capsules 59 colonic polyps 59 malignant tumors 59 AAT deficiency 59 glioblastoma multiforme GBM 59 hepatorenal syndrome 59 imatinib Gleevec 59 bladder ovarian 59 micrometastases 59 pituitary tumors 59 tumor necrosis 59 carotid plaques 59 bullous 59 Metastatic 59 invasive carcinomas 59 malignant ascites 59 BRCA mutations 59 postoperative pathology 59 postoperative delirium 59 ocular melanoma 59 biliary tract cancers 59 Glioblastoma Multiforme 59 stage IIIB 59 pancreatic colon 59 familial adenomatous polyposis 59 microsatellite instability 59 HNPCC 59 Trichomonas vaginalis 59 lymph node enlargement 59 Lung transplantation 59 neovascular 59 Lymphomas 59 juvenile idiopathic arthritis JIA 59 chronic rhinosinusitis 59 LRP5 59 HER2 receptor 59 clinicopathological 59 medically inoperable 59 hypertrophic scars 59 hypermethylated 59 thromboembolic events 59 acute humoral rejection 59 autosomal dominant polycystic kidney 59 lymphadenectomy 59 metastatic GIST 59 immunohistochemical staining 59 CagA 59 ADAMTS# 59 prostate cancer CRPC 59 androgen dependent 59 mitochondrial toxicity 59 recurrent ovarian cancer 59 pancreatic endocrine 59 colorectal liver metastases 59 E. faecalis 59 Li Fraumeni Syndrome 59 epithelial ovarian cancer 59 interleukin IL -# 59 gastroesophageal junction 59 hemorrhagic complications 59 nonmelanoma skin cancer 59 Gorlin syndrome 59 medullary thyroid cancer 59 APOL1 59 haematopoietic 59 hypovitaminosis D 59 S. aureus isolates 59 transplantation HCT 59 Malignant Melanoma 59 Wilms tumors 59 smoldering myeloma 59 familial ALS 59 CIN3 59 neuropathies 59 Pleural mesothelioma 59 lumbar disk herniation 59 MYCN amplification 59 Hashimoto thyroiditis 59 lymphoid cells 59 hematopoietic cancers 59 embryonal rhabdomyosarcoma 59 Hurler syndrome 59 cancerdefine 59 obstructive coronary 59 polyp recurrence 59 papillary thyroid carcinoma 59 bexarotene 59 CMV retinitis 59 ATTR CM 59 testicular tumors 59 IGFBP2 59 CMV disease 59 KRAS mutations 59 thyroid carcinoma 59 anterior uveitis 59 Aspergillosis 59 extracapsular extension 59 Medullary thyroid cancer 59 squamous histology 59 chromosomal aberrations 59 hypercalcaemia 59 Relapsing remitting MS 59 methicillin susceptible Staphylococcus aureus 59 chemoresistant 59 allogeneic HSCT 59 medulloblastomas 59 colorectal pancreatic 59 Non Alcoholic Fatty 59 sarcosine 59 gynecologic malignancy 59 esophagogastric junction 59 hepatic metastases 59 multiple myeloma MM 59 synovial sarcoma 59 cervical lesions 59 Glioma 59 Aortic stenosis 59 mucormycosis 59 Glioblastoma multiforme GBM 59 occlusive disease 59 thrombocytopenic 59 intracranial hemorrhage ICH 59 cholelithiasis 59 gallstone disease 59 NOMID 59 cutaneous squamous cell carcinoma 59 Atopic eczema 59 solar keratosis 59 mRCC 59 neurologic complications 59 motor neuron degeneration 59 nodal metastases 59 Glioblastoma multiforme 59 lipomas 59 proximal colon 59 undergone radical prostatectomy 59 narcolepsy cataplexy 59 breast cancer metastasis 59 Chronic myeloid leukemia CML 59 Extensively drug 58 lymphoid tumors 58 urothelial bladder cancer 58 Adjuvant chemotherapy 58 relapsed ovarian cancer 58 tissue fibrosis 58 hyperintense lesions 58 Melanomas 58 herpes simplex encephalitis 58 post transplant lymphoproliferative 58 inflammatory bowel diseases 58 rs# [001] 58 CaP 58 abdominal adiposity 58 lymphomas leukemias 58 HER2 neu 58 Candida infections 58 GSTP1 58 transthyretin amyloidosis 58 poorer prognosis 58 metastatic liver 58 liver resection 58 myositis 58 Li Fraumeni 58 cervical intraepithelial neoplasia 58 Tumours 58 GABHS 58 autoimmune pancreatitis 58 erythema nodosum 58 biochemical recurrence 58 invasive ductal breast cancer 58 spinocerebellar ataxia 58 spinal metastases 58 myeloid leukemia 58 pre cancerous growths 58 oesophagitis 58 IGFBP 3 58 lung nodules 58 cell carcinoma 58 monocytic 58 prostate ovarian 58 B7 H3 58 baseline LDH 58 Mitomycin C 58 diffuse gastric 58 extrapleural pneumonectomy 58 PTEN protein 58 HGPIN 58 progesterone receptor negative 58 disease NAFLD 58 metastatic malignant 58 osteoid osteoma 58 colorectal 58 serotype #A 58 adjuvant radiation 58 inherited mutations 58 CTEPH 58 osteoid 58 elevated triglyceride levels 58 herpesviruses 58 adriamycin 58 cardiac dysfunction 58 lymphadenopathy 58 proctitis 58 susceptibility loci 58 fallopian tube cancers 58 synovial fibroblasts 58 solid tumors 58 colon pancreas 58 MSH2 58 genetic polymorphisms 58 total thyroidectomy 58 imatinib resistance 58 anti angiogenic agents 58 acute rheumatic fever 58 castrate resistant prostate cancer 58 Colorectal cancer CRC 58 fluoroquinolone resistance 58 intracranial tumors 58 carcinoid cancer 58 tumor metastases 58 fibrosis cirrhosis 58 lupus scleroderma 58 Kaposi sarcoma 58 hematologic disorders 58 colorectal adenomas 58 LVNC 58 Beta thalassemia 58 KRAS mutations occur 58 alkaline phosphatase ALP 58 papular 58 sinonasal 58 hepatic lesions 58 transitional cell carcinoma 58 collagenous colitis 58 gastric corpus 58 immunohistochemical 58 rheumatic diseases 58 Epithelial ovarian cancer 58 systemic fungal infections 58 IPAH 58 obstructive jaundice 58 Brain metastases 58 Mantle Cell Lymphoma 58 endometrial ovarian 58 Clusterin 58 curative resection 58 uterine tumors 58 chemoembolization 58 bone metastasis 58 underlying vasculopathy 58 eosinophilic 58 Sudhir Agrawal D.Phil 58 Rectal cancer 58 hypercalcemia 58 bile duct cancers 58 localized prostate 58 cell acute lymphoblastic 58 lymphatic tissue 58 fibromatosis 58 posterior uveitis 58 IL 1β 58 liver colon rectal 58 juvenile myelomonocytic leukemia 58 arthritis PsA 58 thyrotoxicosis 58 pancreatic 58 Burkitt lymphoma 58 androgen receptor AR 58 Benign breast 58 minimally symptomatic 58 calculi 58 thymic carcinoma 58 simplex virus 58 liver fibrosis 58 lymph node removal 58 Helicobacter pylori 58 uterine cervix 58 Adenocarcinoma 58 KRAS wild 58 cerebral infarction 58 Acute lymphoblastic leukemia 58 biliary strictures 58 lymphoid 58 follicular lymphoma FL 58 hypercoagulable 58 Hemorrhagic 58 hematopoietic malignancies 58 somatic mutations 58 Prognostic factors 58 V#F mutation 58 gefitinib Iressa 58 Acute myeloid leukemia 58 CMV infection 58 benign proliferative breast 58 cancer mCRC 58 ovarian carcinomas 58 chronic hepatitis cirrhosis 58 osteochondromas 58 fibroma 58 relapsed leukemia 58 histopathologic examination 58 tuberous sclerosis TS 58 benign polyps 58 adjuvant radiotherapy 58 melanocytic 58 intracranial aneurysms 58 chronic myeloid 58 fibrin deposition 58 gastrointestinal malignancies 58 mutated K ras 58 ERBB2 58 macroalbuminuria 58 rectal cancer 58 Chlamydia pneumoniae 58 TCF#L# 58 prostate bladder 58 hematologic malignancies 58 HIV HCV coinfected 58 neoadjuvant treatment 58 neoadjuvant therapy 58 haematological cancers 58 arteriovenous malformations 58 PGDH 58 E#F# 58 intestinal ulcers 58 granulomatous 58 mycobacterial infections 58 metastatic renal cell carcinoma 58 anal cancers 58 gastrointestinal stromal tumor GIST 58 malignant pleural mesothelioma MPM 58 colorectal carcinomas 58 trophoblast cells 58 gefitinib 58 PKCi 58 radical nephrectomy 58 malignant cancerous 58 mTOR inhibitors 58 invasive bladder 58 cirrhotic patients 58 mouse xenograft models 58 SCCHN 58 gastrectomy 58 KRAS status 58 multidrug resistance 58 Colorectal cancers 58 elevated serum creatinine 58 leukemia CLL 58 BRCA mutation carriers 58 pre cancerous lesion 58 pediatric acute lymphoblastic 58 diverticular bleeding 58 esophagitis 58 carcinoembryonic antigen 58 micafungin 58 acute promyelocytic leukemia 58 Oesophageal cancer 58 bladder carcinoma 58 Immunohistochemical staining 58 C. trachomatis 58 cholestasis 58 Aspergillus infections 58 microsphere therapy 58 radiofrequency ablation RFA 58 paraneoplastic 58 BRAF V#E mutation 58 Idiopathic Pulmonary Fibrosis 58 TGF alpha 58 malignant gliomas 58 C#Y 58 SOD2 gene 58 Glioblastoma 58 uterine ovarian 58 transferrin saturation 58 Trichophyton rubrum 58 leukemia APL 58 HBV genotype 58 neoplastic cells 58 polypoid lesions 58 plasminogen activators 58 atypical ductal hyperplasia 58 peritumoral 58 PTPN# 58 vascular disorders 58 ankylosing spondylitis AS 58 androgenetic alopecia 58 Philadelphia Chromosome Positive 58 prophylactic cranial irradiation 58 EpCAM 58 chemoresistance 58 atypical hemolytic uremic syndrome 58 lysosomal storage diseases 58 NNRTI resistance 58 sJIA 58 xenograft tumors 58 oral leukoplakia 58 pelvic lymph nodes 58 necrotizing 58 alveolar epithelial cells 58 pT3 58 CIN2 + 58 benign breast 57 activating mutations 57 clade B 57 infective endocarditis 57 Hepatocellular Carcinoma 57 taxane therapy 57 choroidal neovascularization CNV 57 Renal cell carcinoma 57 precancerous cervical lesions 57 Uterine cancer 57 choroidal neovascularization 57 radiographic findings 57 undergoing radical prostatectomy 57 metastatic 57 standard chemotherapy regimens 57 Ribavirin causes 57 lymphoid tissue 57 hyperinsulinemia 57 breast abscesses 57 ocular disorders 57 differentially expressed genes 57 chronic hepatitis 57 HLA DRB1 * 57 goblet cells 57 invasive fungal infections 57 locoregional 57 lymphocytosis 57 malignant pheochromocytoma 57 G6PD deficiency 57 methylenetetrahydrofolate reductase 57 histologic findings 57 FluCAM arm 57 transaminase elevations 57 liposomal amphotericin B 57 LHON 57 diabetic nephropathy 57 sulfasalazine 57 ovarian prostate 57 ALND 57 GRASPA ® 57 EoE 57 precancerous tumors 57 pan HDAC inhibitor 57 alanine aminotransferase ALT 57 lymphoid malignancies 57 penile cancers 57 non squamous NSCLC 57 multimodality therapy 57 reflux esophagitis 57 adjuvant therapies 57 hepatic fibrosis 57 neuroblastoma tumor